"almost there" found this on YaHoo MB
First, XMDC has plenty of "operational start-up" money in the bank from the 1st round of NEW shares sold, which XMDC sold between .02 and .10 when the first merger PR's were put out------SHAREHOLDERS digested that and it became part of PPS base(.035-.055) that has been building for last 3 weeks.
the next step is to announce "MERGER COMPLETED", set the marketing and sales "tone" for the next 6 months, aprise us of the KFDA and FDA parameters, project the "non-human" strategy, and get down to gaining approval for "human" use-------thats the "WHAT for & WHEN" of the remaining authorized 220M shares...
they will be offered to the (most likely WAVE of interested buyers who are here now and will be ready to buy @ .10) next round of OWNERS in the new company..........$22M to market, build, advertise, INTRODUCE to the medical device world, the BioHarp
AND AGAIN AFTER "DONE PR"
DO you think it will be tough to sell a newly minted XMDC, practically debt free, SEC approved, soon to be KFDA approved(stones throw from largest population on earth), patent protected, skin cancer focused detection device, a nanotechnology based NECESSITY to the WORLD?????
I agree with you, it sounds like a sales pitch for an eager, interested investor group---you guys--you IN?